The global pharmaceutical collaborative robots market size is expected to reach USD 140.58 million by 2030, registering a CAGR of 9.80% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is witnessing a surge in demand as the industry embraces automation to enhance efficiency and compliance. Rapid technological advancements have led to the development of more versatile and user-friendly cobots that seamlessly integrate into pharmaceutical workflows. These robots are addressing challenges such as labor shortages, intricate regulatory requirements, and the need for flexible manufacturing. As pharmaceutical companies strive for agility and innovation, adopting collaborative robots is set to continue, reshaping the industry by improving productivity, quality, and worker safety. In the pharmaceutical industry, cobots are widely used in secondary packaging.
Furthermore, employing robotic automation has become a popular solution to tackle monotonous tasks, allowing employees to focus on more important responsibilities. Moreover, automation ensures that strict regulations and quality control standards are met as it can ensure consistent and accurate processing, which minimizes the risk of human error & contamination. By automating repetitive tasks such as packaging medication, assembling medical devices, and handling samples, productivity and efficiency can be enhanced, allowing employees to concentrate on critical areas, including research & development, increasing production volume and overall efficiency.
Moreover, the increasing demand for automation in clinical trials, drug discovery, and laboratories is driven by industry growth and the high costs of new drug development. To address this, robots can now perform various tasks in the pharmaceutical manufacturing process, such as the VS-050-S2 series from Denso Wave Incorporated. This 6-axis articulated robot can assist in developing, inspecting, packing & packaging, and drug transportation. As a result, innovative robotic technologies have led to more efficient management of tasks and improved workflow in the industry.
In addition, the rise in government initiatives and healthcare spending is fueling growth in developing and deploying healthcare mobile robots. Furthermore, cobots are suitable for implementation in industries of all sizes, from small to large-scale operations. For instance, Universal Robots has successfully deployed over 50,000 cobots across diverse production environments globally. Similarly, Amazon employs over 200,000 mobile robots in its warehouses worldwide.
By application, the picking and packaging segment accounted for the largest revenue share in 2023 due to factors such as increasing demand for streamlined logistics and the need for precision in delivering products to consumers.
By end-use, the pharmaceutical companies segment dominated the market with the largest revenue share in 2023, owing to the growing adoption of collaborative robots by pharmaceutical companies.
The Asia Pacific region dominated the market in 2023 due to the presence of a large number of local pharmaceutical companies in countries such as Japan.
Please note The report will be delivered in 2-3 business days upon order notification.